Diverticulitis & Diverticular Health

Diverticulitis & Diverticular Health: A Comprehensive Nutritional and Natural-Health Reference

1. Definition and Clinical Spectrum

Diverticulosis refers to the presence of diverticula in the colon, diverticulitis refers to the presence of peridiverticular inflammation and infection, and diverticular disease refers to the full spectrum of symptoms caused by the presence of diverticula including cramping, bloating, pain, and fever.

Diverticular disease is a general term that references the presence of diverticula — small pouches in the large intestinal (colonic) wall. These outpouchings arise when the inner layers of the colon push through weaknesses in the outer muscular layers. Diverticulosis can occur anywhere in the colon, but it is most common in the left colon (descending or sigmoid colon).

The prevalence of colonic diverticula is about 5% before the age of 40, while it increases to 50% around 60 years, and exceeds 71% after 80 years. In the United Kingdom alone, 50% of the population above 50 years of age is affected by diverticular disease. Diverticular disease was believed to be associated with increasing age; however, in recent studies, its prevalence in younger populations has increased.

In terms of severity, diverticular disease is classified into symptomatic uncomplicated diverticular disease (SUDD) and symptomatic complicated disease such as acute diverticulitis (with or without complication) or diverticular hemorrhage. SUDD is most commonly defined as gastrointestinal symptoms in the setting of diverticulosis without evidence of overt inflammation or diverticulitis. In about 10–25% of patients with diverticulosis, the disease progresses and leads to diverticulitis.

2. Body Systems Involved and Pathophysiology

Diverticular disease is common and thought to result from structural abnormalities of the colonic wall, disordered intestinal motility, or deficiencies of dietary fiber. The common theories with respect to the development of diverticulosis focus on three areas: structural abnormalities of the colonic wall, disordered motility, and the role of dietary fiber.

The development of diverticulosis has historically been attributed to a combination of increased intracolonic pressure and weakness in the colon wall. Higher intracolonic pressure has been attributed to low intake of fiber, whereas weakness in the colon wall might be associated with ageing.

The role of inflammation in the development of diverticular disease and progression of symptoms has been an increasing topic of discussion. It is clear that overt peritoneal inflammation associated with pain, leukocytosis, and fever is the hallmark of acute diverticulitis, but lower levels of chronic inflammation may also play a role in the pathogenesis of the disorder.

The most common presentation of diverticular disease is pain in the abdomen or a change in bowel habits. Acute diverticulitis typically produces fever, left lower quadrant abdominal pain, and elevated inflammatory markers such as C-reactive protein (CRP). Chronic colonic active inflammation in the presence of diverticular disease is termed Segmental Colitis Associated with Diverticulosis (SCAD). Its pathophysiology is still indeterminate but together with its clinical picture may mimic Inflammatory Bowel Disease.

2.1 Colonic Wall Structural Changes and Connective Tissue

Individuals with diverticulosis have altered colonic connective tissue composition and collagen metabolism. The type I to type III collagen ratio, cross-linking of collagen fibers, and levels of tissue-degrading matrix metalloproteinases are increased in patients with diverticular disease. It is not clear whether these changes are related to the development of diverticulosis itself or to symptoms and complications of diverticular disease.

2.2 Enteric Nervous System and Motility

Low-grade inflammation, altered intestinal microbiota, visceral hypersensitivity, and abnormal colonic motility have been identified as factors potentially contributing to symptoms. The enteric nervous system plays a role in regulating colonic contractility; disordered motility can contribute to elevated intraluminal pressures that, over time, promote outpouching through anatomical weak points along vascular penetrations in the muscular wall.

2.3 The Gut Microbiome

Of particular relevance in SUDD is the dysregulation of the gut microbiota. Recent studies have identified notable shifts in the fecal microbiome of patients with SUDD, including a reduction in short-chain fatty acid–producing bacteria and a decline in Akkermansia muciniphila, a mucin-degrading bacterium critical for maintaining epithelial barrier function and modulating inflammation.

Observations indicate that IBD, subgroups of IBS, and symptomatic diverticular disease share clinical symptoms, and may also share pathophysiological factors like low-grade inflammation, changed microbiota composition and activity, and increased intestinal permeability.

3. Contributing and Associated Factors

3.1 Age

Colonic diverticulosis is common in industrialized nations and the prevalence increases dramatically with increasing age. The increase in the incidence of diverticulosis with age suggests that, in most cases, neuromuscular alterations might be linked to ageing rather than genetic factors.

3.2 Genetics

Genome-wide association studies (GWAS) have identified diverticulosis risk loci that contained genes involved in connective tissue integrity and intestinal motility, highlighting the importance of neuromuscular abnormalities in the development of diverticulosis. Identified in GWAS studies, gene candidates may be grouped into blood group and immune system-related genes, extracellular matrix and connective tissue genes, signaling and cell communication, and nervous system and neurodevelopment categories.

Twelve of the risk genes in diverticular disease are also involved in monogenic syndromes involving neuromuscular, connective tissue stability disorders, and morphogenesis traits. This suggests that polygenic diverticular disease is a disorder of impaired connective fibers support, intestinal neuromuscular, and mesenteric vascular smooth muscle function.

While dietary habits, obesity, smoking, and physical inactivity contribute to its pathogenesis, emerging evidence highlights a genetic predisposition affecting extracellular matrix (ECM) remodeling, inflammation, and connective tissue integrity.

3.3 Obesity and Body Composition

Obesity has been shown to increase the risk of diverticulitis by up to 80%. Associations between acute diverticulitis and waist circumference, waist-to-hip ratio, and body mass index have been identified. Based on these findings, 14.7 cases of diverticulitis and 8.2 cases of diverticular bleeding would be expected to occur per 1,000 obese men compared with 6.6 cases of diverticulitis and 2.6 cases of diverticular bleeding in 1,000 men with BMI < 21. A positive association of diverticulitis with waist-to-hip ratio and weight gain was also observed.

3.4 Physical Inactivity

The benefits of physical activity on diverticulitis and diverticular bleeding have been shown with ≥ 30 minutes of exercise per day. One study found that men with the highest quintile of physical activity had 25 to 46% risk reduction compared with those in the lowest quintile. Importantly, the effect of physical activity persisted even when controlling for obesity. Conversely, those with sedentary lifestyles, classified by sitting for ≥ 5 hours per day, are at increased risk of symptomatic diverticulitis.

3.5 Smoking

Multifactorial effects of smoking and nicotine may promote inflammatory conditions of the gastrointestinal tract, such as diverticulitis. Smoking alters the pro-oxidant and antioxidant balance in tissues, causing increases in free radical production and decreases in the levels of protective antioxidants. Smoking also decreases colonic mucosa growth, resulting in impaired endothelial function and altered colonic bacterial composition.

In a Swedish cohort study of 7,500 men over 28 years, patients smoking during the study period had a relative risk of 1.89 (95% CI 1.15–3.10) for perforated diverticular disease compared with non-smokers. In the EPIC-Oxford cohort, there was a relative risk of 1.34 in people who smoked fewer than 15 cigarettes per day and 1.86 in people who smoked 15 or more cigarettes per day for hospitalization for diverticular disease compared with non-smokers.

3.6 Alcohol

Although there are some literatures, mostly observational studies, that raise the possible relation of alcohol to diverticular disease, there is currently no conclusive and convincing evidence that there is a direct relationship between alcohol or caffeine consumption and symptomatic diverticular disease. A more recent large prospective cohort study found that after adjusting for age, sex, BMI, ethnicity, household income, and polygenic risk score tertiles, smoking, alcohol, frequent insomnia, sedentary behavior, and tea consumption were associated with an increased risk of diverticular disease.

3.7 Medication Use

Many authors also consider alterations in colonic microbiota composition, comorbidity with diabetes and hypertension, and the chronic assumption of certain medications like proton pump inhibitors (PPI), angiotensin receptor blockers (ARB), and aspirin as important risk factors for the development of diverticulosis.

4. Dietary Factors

4.1 Dietary Fiber

The most common cause of diverticular disease is believed to be a low-fiber diet. Diets low in fibers are associated with increased intra-colonic pressure, which leads to diverticula formation. The low-fiber diet is thought to predispose to diverticulosis owing to a slower fecal transit time and smaller stool weight.

Fiber intake, achieved by consuming fruits, vegetables, and cereal grains, increases fecal mass and regularizes bowel movements, as well as acts as a colonic prebiotic, favoring health-promoting species of the gut microbiota.

A systematic review and meta-analysis of five prospective cohort studies with 19,282 cases and 865,829 participants confirmed the protective role of fiber. The summary relative risk was 0.74 (95% CI 0.71–0.78) per 10 g/day of dietary fiber, and there was a 23%, 41%, and 58% reduction in risk for an intake of 20, 30, and 40 g/day, respectively, compared to 7.5 g/day. The summary relative risk per 10 g/day was 0.74 (95% CI 0.67–0.81) for cereal fiber, 0.56 (95% CI 0.37–0.84) for fruit fiber, and 0.80 (95% CI 0.45–1.44) for vegetable fiber.

A high intake of fiber was associated with a decreased risk of diverticulitis or hospitalization due to diverticular disease, with a protective effect for fruits and cereal fiber, but not for vegetable fiber; whereas a high red meat consumption and a generally Western dietary pattern were associated with an increased risk of diverticulitis.

The landmark Health Professionals Follow-up Study is among the strongest evidence. Total dietary fiber intake was inversely associated with the risk of diverticular disease after adjustment for age, energy-adjusted total fat intake, and physical activity (relative risk 0.58; 95% CI 0.41, 0.83; P for trend = 0.01 for men in the highest compared with the lowest quintile of dietary fiber). This inverse association was primarily due to fruit and vegetable fiber. For men on a high-total-fat, low-fiber diet, the relative risk was 2.35 (95% CI 1.38, 3.98), and for men on a high-red-meat, low-fiber diet the relative risk was 3.32 (95% CI 1.46, 7.53) compared with those on a low-red-meat, high-fiber diet.

4.2 Red Meat and Western Dietary Patterns

Lifestyle factors associated with increased risk include Western dietary patterns (high in red meat, fat, and refined grains) and red meat consumption alone. Obesity, and central obesity in particular, increases the risk of diverticulitis. Smoking is also associated with an increased risk of diverticulitis — particularly complicated diverticulitis. On the other hand, dietary fiber intake and prudent diets (high in fruits, vegetables, and whole grains) reduce the risk of diverticulitis.

4.3 Vegetarian and Vegan Diets

The prevalence of diverticular disease in British vegetarians in the late 1970s was reported to be approximately one-third that of meat eaters. The more recent European Prospective Investigation into Cancer and Nutrition (EPIC) prospective study showed that vegans have a 72% reduced risk of diverticular disease, compared with meat eaters. Researchers note that fiber intake and the avoidance of meat are not entirely independent variables.

4.4 Nuts, Seeds, and Popcorn: A Revised Understanding

For decades, patients with diverticular disease were advised to avoid nuts, seeds, corn, and popcorn based on the theoretical concern that these foods could become lodged in diverticular pouches. Patients with diverticular disease are frequently advised to avoid nuts, corn, popcorn, and seeds to reduce the risk of complications. However, there is little evidence to support this recommendation.

The Health Professionals Follow-up Study — a cohort followed prospectively from 1986 to 2004 — enrolled 47,228 men aged 40–75 years who were free of diverticulosis or its complications, cancer, and inflammatory bowel disease at baseline. During 18 years of follow-up, there were 801 incident cases of diverticulitis and 383 incident cases of diverticular bleeding. Inverse associations were found between nut and popcorn consumption and the risk of diverticulitis. The multivariable hazard ratios for men with the highest intake (at least twice per week) compared to the lowest (less than once per month) were 0.80 for nuts (P for trend 0.04) and 0.72 for popcorn (P for trend 0.007).

Pooling data from nine observational studies covering more than two million person-years, researchers found no evidence that eating nuts is harmful in diverticulosis — and even some indications that nuts and seeds may offer modest protection against inflammation. Current guidelines no longer recommend avoiding nuts, seeds, or popcorn between flare-ups for people with diverticulosis. The American Gastroenterological Association and the UK's National Institute for Health and Care Excellence (NICE) both state that there is no need to exclude these foods from the diet.

4.5 Hydration

Fiber softens stool and adds bulk, making it easier to pass and reducing strain on the colon. Pairing fiber-rich foods with adequate hydration is key. Adequate fluid intake supports fiber's ability to increase stool bulk and transit speed, an effect particularly important for insoluble fiber sources.

5. Nutrients, Herbs, and Natural Ingredients

5.1 Dietary Fiber (as a Functional Nutrient)

Scientific evidence (strong, prospective cohort and meta-analysis data): As detailed in Section 4.1, dietary fiber — particularly cereal and fruit fiber — is the most evidence-supported nutritional intervention for reducing the risk of diverticular disease. Evidence indicates that the insoluble component of fiber is strongly associated with lower risk of diverticular disease; this association was particularly strong for cellulose. Fibers are edible plant components or the analogous carbohydrates that are resistant to digestion/absorption in the small intestine, with partial or complete colonic fermentation.

5.2 Probiotics

Rationale: In recent literature, the role of gut microbiome imbalance in the onset of the different manifestations within the clinical spectrum of diverticular disease has been highlighted. In the context of diverticular disease, probiotics are useful because they counteract the adhesion of harmful bacteria to the intestinal mucosa, modify the metabolic aspects at the mucosal level, and reduce the synthesis of inflammatory cytokines.

Scientific evidence (preliminary to moderate; RCTs and systematic reviews): A 2024 systematic review and meta-analysis including 13 studies found that probiotic therapy was associated with improvement in abdominal pain (SMD 0.63; 95% CI: 0.38–0.88). However, the evidence for the recommended use of probiotics in clinical practice for management of diverticular disease is still a matter of controversy.

An earlier 2016 systematic review was more cautious: a meta-analysis on the efficacy of probiotics in diverticular disease could not be performed due to the poor quality of retrieved studies. This systematic review showed that high-quality data on the efficacy of probiotics in diverticular disease are scant: the available data do not permit conclusions. Further investigation is required to understand how probiotics can be employed in this condition.

A 2018 systematic review noted that 13 studies were included, comprising 3 double-blind randomized placebo-controlled, 6 open randomized, and 4 non-randomized open studies. Even though the majority of studies are still preliminary, current data show a possible clinical application of certain probiotic strains in all stages of diverticular disease.

Concerning secondary prevention after acute diverticulitis, no randomized controlled trials have specifically evaluated the role of probiotics in preventing recurrence after acute diverticulitis, and available data are restricted to SUDD. Thus, probiotics cannot be considered effective but have only been insufficiently studied in this setting.

5.2.1 Limosilactobacillus reuteri ATCC PTA 4659 (formerly Lactobacillus reuteri)

Scientific evidence (two RCTs; preliminary): L. reuteri ATCC PTA 4659 showed a potent anti-inflammatory action by inhibiting experimental colitis in IL-10-deficient transgenic mice, while also reducing the levels of proinflammatory cytokines such as TNF-α.

In a double-blind, placebo-controlled RCT (n = 88) in patients with acute uncomplicated diverticulitis, patients received either ciprofloxacin and metronidazole plus L. reuteri twice daily for 10 days, or the same antibiotic therapy plus placebo. Between days 1 and 3, the probiotic group pain decreased by 4.5 points versus 2.36 points in the placebo group on the visual analog scale (p < 0.0001).

A second double-blind RCT (n = 119) examined L. reuteri ATCC PTA 4659 in the absence of antibiotics. In this trial, 119 patients with acute uncomplicated diverticulitis were enrolled; the probiotic group (61 patients) was treated with fluids, bowel rest, and L. reuteri twice daily for 10 days. Supplementation with L. reuteri 4659 together with bowel rest and fluids significantly reduced both blood and fecal inflammatory markers compared to the placebo group. These results are preliminary and require replication in larger trials.

5.3 Vitamin D

Scientific evidence (observational and one post-hoc RCT analysis; preliminary): Geographical and seasonal variations have led to the hypothesis that low vitamin D status is associated with increased risk of diverticular disease. This hypothesis was supported by results from a retrospective cohort study, which found that higher serum 25-hydroxyvitamin D (25(OH)D) levels in patients with uncomplicated diverticular disease were associated with a lower risk of diverticular disease hospitalization.

However, due to the observational design and limited research on this topic, the causal relationship between vitamin D and diverticular disease remains unclear; clinical trial data are warranted. A post-hoc analysis of a community-based, randomized double-blind, placebo-controlled trial enrolled 5,108 participants randomized to receive monthly 100,000 IU vitamin D or identical placebo. Some studies have linked low vitamin D status and high risk of diverticular disease, but the causal relationship between vitamin D and diverticular disease remains unclear; clinical trial data are warranted. Overall, the evidence for vitamin D supplementation in diverticular disease is currently insufficient to draw firm conclusions.

5.4 Curcumin (from Turmeric, Curcuma longa)

Traditional use: Turmeric has been used for centuries in Ayurvedic and traditional Chinese medicine as a digestive tonic and anti-inflammatory agent, administered as a prepared decoction or incorporated into food. Its root powder and preparations have historically been applied to conditions involving abdominal discomfort, digestive complaints, and inflammatory states of the gastrointestinal tract.

Scientific evidence (animal/preclinical; no direct human RCTs in diverticular disease): Studies in animal models have shown curcumin can inhibit tumor necrosis factor-alpha, one of the inflammatory chemical messengers associated with diverticular disease and acute diverticulitis. Clinical trials to evaluate the specific effect of these natural anti-inflammatory agents in diverticular disease are still needed. Evidence for curcumin's direct use in diverticular disease is currently limited to preclinical and indirect data; no clinical trials have been conducted specifically in diverticular disease populations.

5.5 Omega-3 Fatty Acids (EPA and DHA)

Scientific evidence (indirect/general anti-inflammatory; no diverticular-disease-specific RCTs): Emerging evidence suggests an overlap between the inflammation that characterizes chronic diverticular disease and that of IBD. EPA and DHA have been extensively studied for their general anti-inflammatory activity, and many studies have demonstrated that omega-3 fats are beneficial in IBD. Clinical trials to evaluate the specific effect of these natural anti-inflammatory agents in diverticular disease are still needed. Direct clinical evidence for omega-3 fatty acids in diverticular disease is therefore lacking, and any extrapolation from IBD data is speculative.

5.6 Mesalazine (5-Aminosalicylic Acid / 5-ASA)

Note: Mesalazine is a pharmaceutical anti-inflammatory agent rather than a traditional herbal remedy, but it is frequently discussed in natural-health and nutrition contexts as a gut-targeted anti-inflammatory and has been trialled alongside dietary interventions for SUDD.

Scientific evidence (mixed RCT data): Studies with different designs have investigated the use of mesalazine in diverticular disease and found contradicting results on achieving disease remission and preventing recurrences. A systematic review of six RCTs enrolling 1,021 patients found that symptom relief with mesalazine was always larger than that with placebo and other therapies. However, absolute risk reduction was significant only when mesalazine was compared with placebo, a high-fiber diet, and low-dose rifaximin. The incidence of diverticulitis with mesalazine was lower than that observed with placebo and other treatments, being significant only when compared with placebo. Mesalazine is effective in achieving symptom relief and primary prevention of diverticulitis in patients with SUDD.

However, a 2026 narrative review found that large randomized trials have not demonstrated a reduction in recurrence with mesalazine or rifaximin. The body of evidence for mesalazine in secondary prevention (after an episode of acute diverticulitis) is therefore mixed and inconsistent.

5.7 Rifaximin

Scientific evidence (moderate; primarily for SUDD symptom control): Rifaximin, a non-absorbable antibiotic, is a common therapeutic choice for symptomatic diverticular disease in various countries, including Italy. Because of its low systemic absorption and high concentration in stools, it is an excellent medicine for targeting the gastrointestinal tract, where it has a beneficial effect in addition to its antibacterial properties. Treatments for SUDD usually include fiber, antibiotics such as rifaximin, anti-inflammatory drugs such as mesalazine or balsalazide, and probiotics, either alone or in combination. There is limited research on the use of rifaximin for the secondary prevention (preventing recurrence) of acute diverticulitis.

6. Dietary and Lifestyle Factors: Synthesis of Authoritative Evidence

6.1 High-Fiber Diet

A diet high in fiber mainly from fruits and vegetables and low in total fat and red meat decreases risk of diverticular disease. Evidence indicates that the insoluble component of fiber is strongly associated with lower risk of diverticular disease; this association was particularly strong for cellulose. These results suggest that a high fiber intake may reduce the risk of diverticular disease and individuals consuming 30 g of fiber per day have a 41% reduction in risk compared to persons with a low fiber intake.

6.2 Avoidance of Red Meat and Processed Foods

Prospective data support the hypothesis that a diet low in total dietary fiber increases the incidence of symptomatic diverticular disease. They also provide evidence that the combination of high intake of total fat or red meat and a diet low in total dietary fiber particularly augments the risk.

6.3 Regular Physical Activity

Physical activity has been shown to reduce the risk of diverticulitis by 25%. These observations suggest that modifiable risk factors are of major importance for the development of diverticular disease.

6.4 Healthy Body Weight

A relationship between body mass index (BMI) and diverticular disease was demonstrated; men with a BMI between 20 and 22.5 kg/m² had the lowest risk. Maintaining a healthy weight and avoiding central obesity is supported as a preventive strategy across multiple observational studies and meta-analyses.

6.5 Smoking Cessation and Alcohol Moderation

Across all genetic backgrounds, lifestyle factors such as smoking cessation, reduced alcohol intake, good sleep habits, high coffee consumption, low tea consumption, and a healthy diet characterized by higher consumption of fruits, vegetables, whole grains, and fish, along with lower intake of processed meats and unprocessed red meat, were linked to a lower risk of colonic diverticular disease.

6.6 Sleep

After adjusting for multiple confounders, frequent insomnia was associated with an increased risk of diverticular disease. Conversely, intermediate sleep duration was associated with a lower diverticular disease risk. This association, identified in a large prospective cohort study, warrants further mechanistic investigation but highlights sleep as an underrecognized lifestyle variable in diverticular health.

6.7 Antibiotics and Gut Microbiome Perturbation

The American Gastroenterology Association suggests that antibiotics should be used selectively, rather than routinely, in patients with acute uncomplicated diverticulitis. This represents a significant shift from earlier clinical practice and reflects growing understanding of the importance of gut microbiome preservation in diverticular disease management.

6.8 The Nuts and Seeds Myth

The advice to avoid seeds, nuts, and popcorn became standard practice among physicians in the mid-20th century. This recommendation was not based on rigorous scientific evidence but rather on theoretical concerns about how these foods might interact with diverticular pouches in the colon. Today, we know the advice was wrong. The evidence does not show a higher risk of diverticulitis in people who eat a lot of foods like nuts, seeds, or popcorn compared with people who don't.

7. Evidence Gaps and Limitations

The pathophysiology of diverticular disease as well as the mechanisms involved in the shift from an asymptomatic condition to a symptomatic one is still poorly understood. No study currently meets the criteria for being a high-quality study in the area of dietary habits and prevention of diverticular disease complications. Most evidence for nutritional and natural interventions in diverticular disease — with the exception of dietary fiber — derives from observational data, small RCTs, animal studies, or extrapolation from related conditions such as IBD. Natural agents including curcumin, omega-3 fatty acids, and Boswellia serrata have plausible anti-inflammatory rationales but lack direct clinical trial evidence in diverticular disease populations.

References

• Stam MAW et al. "Diverticular Disease: A Review on Pathophysiology and Recent Evidence." PMC, 2020.
• Comparato G et al. "Etiology and Pathophysiology of Diverticular Disease." PMC (Gastroenterology Clinics of North America), 2009.
• Strate LL. "Epidemiology and Pathophysiology of Diverticular Disease." PMC (Gastroenterology Clinics of North America), 2009.
• Strate LL, Morris AM. "Epidemiology, Pathophysiology, and Treatment of Diverticulitis." Gastroenterology, 2019. PMC.
• Carabotti M et al. "Pathophysiology of Diverticular Disease: From Diverticula Formation to Symptom Generation." PMC, 2022.
• Swaminathan A et al. "Diverticulosis and Diverticulitis: Epidemiology, Pathophysiology, and Current Treatment Trends." PMC (Cureus), 2023.
• Aldoori W, Ryan-Harshman M. "Preventing diverticular disease. Review of recent evidence on high-fibre diets." PMC (Canadian Family Physician), 2002.
• Aune D et al. "Dietary fibre intake and the risk of diverticular disease: a systematic review and meta-analysis of prospective studies." PMC (European Journal of Nutrition), 2020.
• Carabotti M et al. "Role of Dietary Habits in the Prevention of Diverticular Disease Complications: A Systematic Review." PMC (Nutrients), 2021.
• Aldoori WH et al. "A prospective study of diet and the risk of symptomatic diverticular disease in men." American Journal of Clinical Nutrition, 1994.
• Spiridon IA et al. "The Impact of Probiotics on Clinical Outcomes in Diverticular Disease: A Systematic Review and Meta-Analysis." PMC, 2025.
• Tursi A et al. "Microbiota Composition in Diverticular Disease: Implications for Therapy." PMC (International Journal of Molecular Sciences), 2022.
• Lahner E et al. "Probiotics in the Treatment of Diverticular Disease. A Systematic Review." PubMed (Journal of Gastrointestinal and Liver Diseases), 2016.
• Tursi A et al. "The Use of Probiotics in Different Phases of Diverticular Disease." PubMed (Reviews on Recent Clinical Trials), 2018.
• Tursi A et al. "Diverticular Disease and Rifaximin: An Evidence-Based Review." PMC (Antibiotics), 2023.
• Picchio M et al. "Mesalazine for the Treatment of Symptomatic Uncomplicated Diverticular Disease of the Colon and for Primary Prevention of Diverticulitis: A Systematic Review of Randomized Clinical Trials." PubMed (Journal of Clinical Gastroenterology), 2016.
• Lahner E et al. "Mesalazine for People with Diverticular Disease: A Systematic Review of Randomized Controlled Trials." PMC (United European Gastroenterology Journal), 2018.
• Kruis W et al. "Randomised clinical trial: mesalazine versus placebo in the prevention of diverticulitis recurrence." PMC (Alimentary Pharmacology & Therapeutics), 2017.
• Frontiers in Surgery. "Risk-stratified pharmacologic strategies for secondary prevention after acute diverticulitis: an exploratory narrative review." 2026.
• Zullo A et al. "Epidemiology and risk factors for diverticular disease." PMC (Acta Biomedica), 2019.
• Hawkins AT et al. "Pathophysiology and Epidemiology of Diverticular Disease." PMC (Clinics in Colon and Rectal Surgery), 2021.
• Bharucha AE, Parthasarathy G. "Epidemiology and Pathophysiology of Diverticular Disease." PMC (Clinics in Colon and Rectal Surgery), 2018.
• Aune D et al. "Body mass index and physical activity and the risk of diverticular disease: a systematic review and meta-analysis of prospective studies." PMC (European Journal of Nutrition), 2017.
• Lifestyle, genetic susceptibility, and risk of diverticular disease: a prospective cohort study. PMC, 2025.
• Maguire LH et al. "Effect of monthly vitamin D on diverticular disease hospitalization: Post-hoc analysis of a randomized controlled trial." PubMed (Clinical Nutrition), 2020.
• Maguire LH et al. "Higher Serum Levels of Vitamin D are Associated with Reduced Risk of Diverticulitis." PMC, 2013.
• Ojetti V et al. "Randomized control trial on the efficacy of Limosilactobacillus reuteri ATCC PTA 4659 in reducing inflammatory markers in acute uncomplicated diverticulitis." PMC (European Journal of Gastroenterology & Hepatology), 2022.
• Petruzziello C et al. "Supplementation with Lactobacillus reuteri ATCC PTA 4659 in patients affected by acute uncomplicated diverticulitis: a randomized double-blind placebo controlled trial." International Journal of Colorectal Disease, 2019.
• Strate LL et al. "Nut, corn, and popcorn consumption and the incidence of diverticular disease." PMC (JAMA), 2008.
• Semmelweis University. "Semmelweis researchers crack the myth linking nuts to diverticulitis." 2025.
• Strate LL, Peery AF, Neumann I. "Colonic diverticular disease." PMC (Nature Reviews Disease Primers), 2020.
• Genetic Determinants of Colonic Diverticulosis—A Systematic Review. PMC, 2025.
• Genetic, epigenetic and environmental factors in diverticular disease: systematic review. PMC, 2024.
• Colonic Diverticulosis: Is there a Genetic Component? PMC, 2020.
• Tursi A. "Etiopathogenetic Mechanisms in Diverticular Disease of the Colon." PMC (Journal of Clinical Gastroenterology), 2019.
• Physicians Committee for Responsible Medicine. "Diverticular Disease." Nutrition Guide for Clinicians.